Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
-dimensional scaffolds using FDM 3D printing for cell culture applications. Develop and optimize biomimetic materials with controlled mechanical and biochemical properties. Functionalize scaffolds with
-
for 3 years. Responsibilities The successful candidate will: Develop, optimize and validate advanced 3D cell culture models, including spheroids, organoids and tissue-engineered constructs. Establish
-
engineering, bioengineering, biomaterials, materials science, tissue engineering, biotechnology, or a related field Hands-on experience in 3D bioprinting Experience in mammalian cell culture Experience in
-
the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description - 3D iPSC cell culture - Differentiation
-
their website at https://www.naritalab.com/ Our laboratory investigates the biology of preneoplastic cell states, with particular interest in how changes in cell functional identity and plasticity are controlled
-
and validate advanced 3D cell culture models, including spheroids, organoids and tissue-engineered constructs. Establish and apply rotational 3D culture systems such as CelVivo or comparable platforms
-
experiments using cancer and stromal cell models, including CRISPR/Cas9-based genetic approaches to investigate Cx43-dependent mechanisms. Establish and characterise tumour–stromal co-culture and 3D models
-
, tissue processing, microCT, 3D culture, and preclinical animal studies. • Maintain laboratory reagents, cell lines, samples, supplies, and equipment and coordinate use of shared resources across Penn and
-
pluripotent stem cells (iPSCs) will be particularly valued, including the use of iPSC-derived cellular models. Experience in 2D and 3D cell culture, vascular models, bioprinting, and biofabrication techniques
-
, microscopy, and molecular analysis. Some experiments may require careful timing, serial sample collection, or occasional scheduling flexibility. 40% — Human cell culture, co-culture systems, and 3D skin model